Stages II-III Bladder Cancer


Keytruda Immunotherapy Improves Overall Survival in Bladder Cancer (November 10, 2016)

Bladder cancer will be diagnosed in approximately 77,000 people in the United States this year alone. The average age that patients are diagnosed with bladder cancer is 70 years, with 80% of these patients... Continue Reading

Votrient® plus Taxol® Promising in Relapsed and Refractory Bladder Cancer (March 30, 2015)

The treatment combination of Votrient® (pazopanib) plus Taxol® (paclitaxel) appears active against bladder cancer that has not responded to or come back after previous therapy. These findings were presented... Continue Reading

Survival Benefit with Immediate Adjuvant Chemotherapy in Invasive Bladder Cancer (June 23, 2014)

Results from a recent Phase III clinical trial suggest that patients with invasive bladder cancer may benefit from treatment with immediate adjuvant chemotherapy. These finding were presented at the 2014... Continue Reading

Immediate Cisplatin-Based Chemotherapy Extends Progression-Free Survival in Invasive Bladder Cancer (June 17, 2014)

A report at the 2014 American Society of Clinical Oncologists meeting indicates that immediate use of cisplatin-based chemotherapy offers significant improvement in progression-free survival over deferred... Continue Reading

Robotic Bladder Cancer Surgery Safe and Effective (January 24, 2013)

Robotic-assisted surgery for invasive bladder cancer is effective and results in less bleeding and shorter hospital stays when compared to the traditional open procedure, according to the results of a... Continue Reading

Adding Chemotherapy to Radiation Reduces Bladder Cancer Recurrence (April 30, 2012)

Chemotherapy plus radiation reduces the risk of recurrence in muscle-invasive bladder cancer patients by nearly 50% compared to radiation alone, according to the results of a study published in the New... Continue Reading

Study Explores New Approach to Boosting the Immune System after Cancer Treatment (August 24, 2011)

Researchers are seeking participants for a Phase II clinical trial that will explore whether an investigational treatment can help the immune system recover after cancer treatment. Cancer treatments such... Continue Reading

Liposomal Cisplatin Safe for Patients with Renal Insufficiency (June 14, 2011)

Liposomal cisplatin (Nanoplatin®), a chemotherapy drug still in clinical trials, does not cause damage to the kidneys and appears to provide at least equal anti-cancer effects as cisplatin (Platinol®)... Continue Reading

New Bladder-preserving Therapy Promising in Bladder Cancer (November 9, 2010)

A new bladder-preserving approach to treatment of locally invasive bladder cancer appears promising, both for patients for whom radical cystectomy is indicated and for those previously ineligible for curative... Continue Reading

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment... Continue Reading

Radical Cystectomy Improves Survival in Stage II Bladder Cancer (May 4, 2010)

Radical cystectomy can improve outcomes among patients with muscle-invasive bladder cancer but appears to be underused in this patient population. These results were published in the Journal of the National... Continue Reading

Combined Modality Therapy Preserves Bladder and Offers Long-term Survival in Invasive Bladder Cancer (March 18, 2010)

Combined modality therapy (CMT) preserves the bladder, achieves complete response (CR), and offers long-term survival in approximately 70% of patients with invasive bladder cancer, according to the results... Continue Reading

Cancer Caregivers Devote Substantial Time and Effort (September 9, 2009)

On average, informal caregivers of cancer patients devote more than eight hours per day to caregiving. These results were published in Cancer. Informal caregiving is an important part of cancer management.... Continue Reading

Update on the Management of Genitourinary Malignancies (October 12, 2007)

Update on the Management of Genitourinary Malignancies: A Report from the 2007 Annual Meeting of the American Society of Clinical Oncology (ASCO) Kidney cancer, the orphan disease that had only one approved... Continue Reading

Improved Outcomes with Higher Volumes for Radical Cystectomy (August 3, 2007)

Improved Outcomes with Higher Volumes for Radical Cystectomy According to an early online publication in the Journal of Urology, patients with bladder cancer who undergo surgery to remove their bladder... Continue Reading

Markers Associated with Risk for Recurrence in Bladder Cancer (February 5, 2007)

Markers Associated with Risk for Recurrence in Bladder Cancer According to an article recently published in the Lancet Oncology, “markers” may help to predict the risk of cancer recurrences... Continue Reading

Gemzar® and Eloxatin® Promising for Advanced Bladder Cancer (August 21, 2006)

Gemzar® and Eloxatin® Promising for Advanced Bladder Cancer According to an article recently published in the Annals of Oncology, the chemotherapy combination consisting of Eloxatin® (oxaliplatin) and... Continue Reading

High-Volume Hospitals Offer Better Outcomes After Radical Cystectomy and Radical Prostatectomy (May 8, 2006)

High-Volume Hospitals Offer Better Outcomes After Radical Cystectomy and Radical Prostatectomy Among patients undergoing radical cystectomy (removal of bladder) or radical prostatectomy (removal of prostate),... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS